Page last updated: 2024-09-03

y 27632 and Cancer of Pancreas

y 27632 has been researched along with Cancer of Pancreas in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutiongco, MF; Gadegaard, N; Jagiełło, A; Kamphorst, JJ; Mackay, G; McGarry, L; Michalopoulou, E; Munro, J; Olson, MF; Pajic, M; Rath, N; Sumpton, D; Timpson, P; Unbekandt, M; Vennin, C1
Dwinell, MB; Hauser, AD; Roy, I; Williams, CL; Wilson, JM; Zimmerman, NP1
Andrianov, G; Astsaturov, I; Banina, E; Beglyarova, N; Behrens, D; Bobrov, E; Gabitova, L; Golemis, EA; Hoffman, JP; Jablonski, SA; Khazak, V; Lysenko, E; Mukhamadeeva, R; Paz, K; Pressman, M; Restifo, D; Serebriiskii, IG; Skobeleva, N; Weiner, LM; Zhou, Y1
Bi, Y; Liu, X1
Adachi, S; Hanamatsu, T; Hirose, Y; Kawaguchi, J; Kozawa, O; Moriwaki, H; Nakashima, M; Okano, Y; Yamauchi, T; Yasuda, I; Yoshioka, T1

Other Studies

5 other study(ies) available for y 27632 and Cancer of Pancreas

ArticleYear
Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth.
    Cancer research, 2018, 06-15, Volume: 78, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 2-Hydroxyphenethylamine; Amides; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Mice; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridines; rho-Associated Kinases; Signal Transduction

2018
Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.
    Molecular carcinogenesis, 2015, Volume: 54, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Amides; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Deoxycytidine; Enzyme Inhibitors; Gemcitabine; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Pyridines; Quinolones; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; rhoC GTP-Binding Protein; Vasodilator Agents

2015
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Dec-15, Volume: 22, Issue:24

    Topics: Amides; Animals; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Diterpenes; DNA Helicases; DNA-Binding Proteins; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Mice, SCID; NIH 3T3 Cells; Pancreatic Neoplasms; Phenanthrenes; Proto-Oncogene Proteins c-myc; Pyridines; rho-Associated Kinases; Signal Transduction; Transcription, Genetic

2016
Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Oct-03, Volume: 22

    Topics: Amides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Humans; Pancreatic Neoplasms; PPAR alpha; Pyridines; RNA, Messenger

2016
Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.
    Molecular cancer, 2011, Jul-03, Volume: 10

    Topics: Amides; Antibodies, Neutralizing; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Up-Regulation

2011